This diagram illustrates the timeline and current status of various TB vaccine candidates in clinical trials, highlighting the diversity of vaccine types and their potential impact on TB prevention ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually. In a comprehensive review published in Molecular Biomedicine, an international team ...

A live-attenuated tuberculosis (TB) vaccine candidate in development elicits a much more balanced and effective immune response compared to the existing vaccine used across much of the world, ...

Tuberculosis remains a leading cause of infectious mortality worldwide, driven by the airborne transmission of Mycobacterium tuberculosis and the emergence of drug-resistant strains. The only licensed ...

Tuberculosis, or TB, an airborne bacterial respiratory infection, is one of humanity's oldest foes and is today the world's leading cause of death from infectious disease, claiming more than 1.2 ...

A live-attenuated tuberculosis (TB) vaccine candidate in development at Texas Biomedical Research Institute (Texas Biomed) elicits a much more balanced and effective immune response compared to the ...

Effective vaccination against tuberculosis hinges on orchestrating both innate and adaptive immune responses to the intracellular pathogen Mycobacterium tuberculosis. Initial recognition by pattern ...

Expert Rev Vaccines. 2013;12(12):1431-1448. There are two trends in TB vaccine development that warrant mentioning. First, there is a new interest in BCG and novel TB vaccines for prevention of ...

A team of scientists led by Oxford University have made a discovery that could improve our chances of developing an effective vaccine against Tuberculosis. The researchers have identified new ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

A previous analysis examined the public health impact of new tuberculosis vaccines and predicted that a pre-exposure vaccine, targeting the acquisition of infection or primary progression would be ...